Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel
Jade Cury‐Martins, Adriana Pessoa Mendes Eris, Cristina Martinez Zugaib Abdalla, Giselle de Barros Silva, Veronica Paula Torel de Moura, José Antônio Sanches
Abstract
With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.